Genzyme to collaborate on ARSACS research project

Representatives from the Foundation and from Genzyme, a medical biotech company with a focus on rare diseases, have agreed on April 17, 2014 in Montreal to collaborate on the ARSACS research project. Genzyme is a subsidiary of the French multinational pharmaceutical...

Partnership with CIHR Institue of Genetics

The Ataxia of Charlevoix-Saguenay Foundation is pleased to announce a partnership with the CIHR Institute of Genetics and its’ participation to the 2014 “Development of Innovative Therapeutic Approaches for Rare Diseases” Joint Transnational Call....

Large -scale Applied Research 2012 Competition

As part of the ” Large -scale Applied Research 2012 Competition” launched by Genome Canada, the Foundation of Ataxia Charlevoix-Saguenay will provide financial support to the project of Dr. Kym Boycott of the University of Ottawa which is competing for...

Swiss delegation in Montreal in May 2012

As part of the partnership between the Ataxia Charlevoix-Saguenay Foundation, the Brain@mcgill project and the Zurich Neuroscience Center, Mr. Mauro Dell’Ambrogio, Swiss Secretary of State for Education and Research, Mr Mauro Moruzzi, Head of International...

Meeting with Swiss Research Group

As part of the partnership with McGill University, an important meeting was held on September 19 in Montreal with representatives of the Zurich Neuroscience Centre. This first meeting was to promote the ARSACS project to researchers and to identify potential...